News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...


Recent Postings


Archive


Tags

Telaprevir Gilead (GILD) ZALTRAP™ Anadys (ANDS) HALOZYME (HALO) Genentech Idenix (IDIX) Agenus (AGEN ARCA (ABIO) Exelixis (EXEL) Editas (EDIT) SERES THERAPEUTICS (MCRB) Sanofi-Aventis (SAN) NOVOCURE (NVCR) Human Longevity (HLI) AstraZeneca (AZN) Zerenex Array Pharmaceuticals (ARRY) ACADIA (ACAD) Elan (ELN) Amgen (AMGN) Spike Therapeutics (ONCE) OSI (OSIP) Sanofi (SNY) GlaxoSmithKline (GSK) Ridaforolimus Illumina (ILMN) Mirati Therapeutics (MRTX) Merck (MRK) Biogen Idec (BIIB) Anacor (ANAC) IDERA (IDRA) ImmunoGen (IMGN) MODERNA Onyx (ONXX) Regeneron (REGN) KITE (KITE) Auspex (ASPX) Seattle Genetics (SGEN) SYNTA (SNTA) GUARDIAN HEALTH Prosensa (RNA) Advaxis (ADXS) Agenus (AGEN) Multiple Myeloma Intrexon (XON) BIOMARIN (BMRN) Rapamune REGULUS (RGLS) Alder Biopharmaceuticals (ALDR) Benlysta (belimumab) NEKTAR (NKTR)) Incyte (INCY) Pluristem (PSTI) Ziofpharm (ZIOP) ISIS (ISIS) Vitae Pharmaceuticals (VTAE) Trastuzumab-DM1 Jazz Pharmaceuticals (JAZZ) Bellicum (BLCM) Theravance Bio Pharma (TBPH) Endometrial Cancer Sequenom (SQNM) VANDA (VNDA) Herceptin Galena (GALE) Dendreon (DNDN) Alnylam (ALNY) AERIE PHARMACEUTICALS C4 Therapeutics Roche (ROCHE) JUNO (JUNO) Tysabri Theravance (THRX) TOKAI (TKAOI) Cytokinetics (CYTK) Micromet (MITI) Xoma (XOMA) Bristol-Myers Squibb (BMY) CRISPR Therapeutics (CRSP) galapagos (GLPG) RenenxBio (RGNX) Ariad (ARIA) SUNESIS PHARMACEUTICALS (SNSS) ADVENTRIX (ANX) Intermune (ITMN) ARGOS (ARGS) Sangamo (SGMO) Biocryst (BCRX) Intercept (ICPT) AGOS (ARGS) Roche (RHHBY) Aimmune Therapeutics (AIMT) Velcade (bortezomib) PTC Therapeutics (PTCT) Abbott Laboratories (ABT) Ionis (IONS) INNOVIVA (INVA) Vertex (VRTX) Global Cell Therapeutics (GBT) Sarepta (SRPT) KERYX (KERX) Human Genome Sciences (HGSI) Sanofi (SNA) CompuGen (CGEN) ABBVIE (ABBV) Prolor Biotech (PBTH) Revlimid (lenolidamide) Adaptimmune (ADAP) Dynavax (DVAX) Valeant Pharmaceuticals International (VRX) Inovio (INO) NANTKWEST (NK)